Tuomas Mirtti

Person

    Research areas

  • 3111 Biomedicine - pathology, urology, cancer, prostate, biomarkers

Latest publications

  1. ITGB1-dependent upregulation of Caveolin-1 switches TGF beta signalling from tumour-suppressive to oncogenic in prostate cancer

    Pellinen, T., Blom, S., Sanchez, S., Välimäki, K., Mpindi, J-P., Azegrouz, H., Strippoli, R., Nieto, R., Viton, M., Palacios, I., Turkki, R., Wang, Y., Sanchez-Alvarez, M., Nordling, S., Bützow, A., Mirtti, T., Rannikko, A., Montoya, M. C., Kallioniemi, O. & del Pozo, M. A., 5 Feb 2018, In : Scientific Reports. 8, 1, 14 p., 2338

    Research output: Contribution to journalArticleScientificpeer-review

  2. Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology Comparison of Matched Fresh Frozen, FFPE, and PFPE Tissues

    Högnäs, G., Kivinummi, K., Kallio, H. M. L., Hieta, R., Ruusuvuori, P., Koskenalho, A., Kesseli, J., Tammela, T. L. J., Riikonen, J., Ilvesaro, J., Kares, S., Hirvikoski, P. P., Laurila, M., Mirtti, T., Nykter, M., Kujala, P. M., Visakorpi, T., Tolonen, T. & Bova, G. S., Jan 2018, In : American Journal of Surgical Pathology. 42, 1, p. 103-115 13 p.

    Research output: Contribution to journalArticleScientificpeer-review

View all (57) »

Latest activities

  1. A valuable pair: Candidate biomarkers RBM3 and PODXL in urothelial bladder cancer

    Mirtti, T. (Opponent)
    31 Mar 2017

    Activity: ExaminationOpponent of doctoral dissertation

  2. DNA repair defect –related phenotype in clinically significant prostate cancer

    Mirtti, T. (Supervisor)
    2017 → …

    Activity: ExaminationSupervisor or co-supervisor of doctoral thesis

  3. Multiparametric model for prostate cancer precision diagnostics

    Mirtti, T. (Supervisor)
    18 Dec 2015 → …

    Activity: ExaminationSupervisor or co-supervisor of doctoral thesis

View all (5) »

ID: 14265